SEARCH

SEARCH BY CITATION

References

  • BARTON, B.E., JAKWAY, J.P., SMITH, S.R. & SIEGEL, M.I. (1991). Cytokine inhibition by a novel steroid, mometasone furoate. Immunopharmacol. Immunotoxicol., 13, 251261.
  • BLACKWELL, G.J., CARNUCCIO, R., DIROSA, M., FLOWER, R.J., PARENTE, L. & PERSICO, P. (1980). Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature, 287, 147149.
  • BRISTOW, A.F., MOSLEY, K. & POOLE, S. (1991). Interleukin-1β production in vivo and in vitro in rats and mice measured using specific immunoradiometric assays. J. Mol. Endocrinol., 7, 17.
  • CODERRE, T.J., ABBOT, F.V. & MELZACK, R. (1984). Effects of peripheral antisympathetic treatments in tail-flick formalin and autotomy tests. Pain, 18, 1323.
  • CUNHA, F.Q., LORENZETTI, B.B., POOLE, S. & FERREIRA, S.H. (1991). Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol., 104, 765767.
  • DINARELLO, C.A. (1991). The proinflammatory cytokines interleukin-1 and tumour necrosis factor and treatment of septic shock syndrome. J. Infect. Dis., 163, 11771184.
  • DINARELLO, C.A., CANNON, J.G., WOLFF, S.M., BERNHEIM, H.A., BEUTLER, B., CERAMI, A. FIGARI, I.S., PALLADINO, M.A. Jr & O'CONNOR, J.V. (1986). Tumour necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med., 163, 14431450.
  • DINARELLO, C.A., IKEJIMA, T., WARNER, S.J.C., ORENCOLE, S.F., LONNEMANN, G., CANNON, J.G. & LIBBY, P. (1987). Interleukin 1 induces Interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J. Immunol., 139, 19021910.
  • FACCIOLI, L.H., SOUZA, G.E., CUNHA, F.Q., POOLE, S. & FERREIRA, S.H. (1990). Recombinant interleukin-1 and tumour necrosis factor induce neutrophil migration ‘in vivo’ by indirect mechanisms. Agents Actions, 30, 344349.
  • FERREIRA, S.H. (1972). Aspirin-like drugs and analgesia. Nature New Biol., 240, 200203.
  • FERREIRA, S.H., LORENZETTI, B.B., BRISTOW, A.F. & POOLE, S. (1988). Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature, 334, 698700.
  • FERREIRA, S.H., LORENZETTI, B.B. & CORREA, F.M.A. (1978). Central and peripheral antialgesic action of aspirin-like drugs. Eur. J. Pharmacol., 53, 3948.
  • HANNINGTON-KIFF, J.G. (1974). Intravenous regional sympathetic block with guanethidine. Lancet, i, 10191020.
  • HIRATA, F., SCHIFFMANN, E., VENKATASUBAMANIAN, K., SALOMON, D. & AXELROD, J. (1980). A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc. Natl. Acad. Sci. U.S.A., 77, 25332536.
  • LEW, W., OPPENHEIM, J.J. & MATSUSHIMA, K. (1988). Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J. Immunol., 140, 18951902.
  • LUMPKIN, M.D. (1987). The regulation of ACTH secretion by IL-1. Science, 238, 452454.
  • MAHADEVAN, V., MALIK, S.T.A., MEAGER, A., FIERS, W., LEWIS, G.P. & HART, I.R. (1990). Role of tumour necrosis factor in flavone acetic-induced tumour vasculature shutdown. Cancer Res., 50, 55375542.
  • MORSTYN, G. & BURGESS, A.W. (1988). Hemopoietic growth factors: a review. Cancer Res., 48, 56245637.
  • NAKAMURA, M. & FERREIRA, S.H. (1987). A peripheral sympathetic component in inflammatory hyperalgesia. Eur. J. Pharmacol., 135, 145153.
  • POOLE, S., BRISTOW, A.F., SELKIRK, S. & RAFFERTY, B. (1989). Development and application of radioimmunoassays for interleukin-1α and interleukin-1β. J. Immunol. Methods, 116, 259264.
  • RAFFERTY, B., MOWER, J.A., TAKTAK, Y.S. & POOLE, S. (1991). Measurement of cytokine production by the monocytic cell line Mono Mac 6 using novel — immunoradiometric assays for interleukin-1β and interleukin-6. J. Immunol. Methods, 144, 6976.
  • ROBERTSON, J.I.S., KAPLAN, N.M., CALDWELL, A.D.S. & SPEIGHT, T.M. (1983). (eds) β-Blockade in the 1980s: focus on atenolol. Drugs, 25 (Suppl.), 1340.
  • ROTHWELL, N.J. (1991). Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol. Sci., 12, 430436.
  • ROTHWELL, N.J., BUSBRIDGE, N.J., LEFEUVRE, R.A., HARDWICKE, A.J., GAULDIE, J. & HOPKINS, S.J. (1991). IL-6 is a centrally acting endogenous pyrogen in the rat. Can. J. Physiol. Pharmacol., 69, 14651469.
  • SCHINDLER, R., MANCILLA, J., ENDRES, S., GHORBANI, R., CLARK, S.C. & DINARELLO, C.A. (1990). Correlations and interactions in the production of interleukin-6 (IL-6), and tumour necrosis facotr (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood, 75, 4047.
  • SEITZ, M., DEWALD, B., GERBER, N. & BAGGIOLINI, M. (1991). Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J. Clin. Invest., 87, 463469.
  • STREITER, R.M., KUNKEL, S.L., SHOWELL, H.J., REMICK, D.G., PHAN, S.H., WARD, P.A. & MARKS, R.M. (1989). Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science, 243, 14671469.
  • VAN DAMME, J., OPDENAKKER, G., SIMPSON, R.J., RUBIRA, M.R., CAYPHAS, S., VINK, A., BILLIAU, A. & VAN SNICK, J. (1987). Identification of the human 26-kD protein; interferon β2 (IFN-β2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumour necrosis factor. J. Exp. Med., 165, 914919.
  • VANE, J.R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature, 231, 232235.
  • WAAGE, A. & BAKKE, O. (1988). Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology, 63, 299302.